Secondly, do these unimolecular agents target both receptors in the same cell, different cells in different tissues, or both
Eli Lilly), which binds to and activates both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), retatrutide is a triple threat, targeting glucagon (GCG) in addition to GLP-1 and GIP
This information does not take the place of talking to your healthcare provider about your medical condition or treatment
Understanding the risk factors helps you assess your personal likelihood and take preventive action before shedding begins
Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2
The drug works primarily by mimicking the incretin hormone GLP-1, which enhances glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite through central nervous system pathways